Metal passivity as mechanism of metal carcinogenesis: Chromium, nickel, iron, copper, cobalt, platinum, molybdenum

Toxicological and Environmental Chemistry

Volumn 89, Issue 1, 2007, Pages 15-70

  Richardson Boedler, Cornelia ^a,b  

^a American College of Forensic Examiners   (United States)

^b NONE   (United States)

Author keywords

Carcinogenesis; Hydrolysis; Implants; Mechanisms; Occupational; Passive metals

Indexed keywords

BIOCHEMISTRY; CHROMIUM; EPIDEMIOLOGY; HYDROLYSIS; IMPLANTS (SURGICAL); NICKEL; PASSIVATION;

CARCINOGENESIS; METAL PASSIVITY; PASSIVE METALS;

CARCINOGENS;

CARCINOGEN; CHROMIUM; COBALT; COPPER; IRON; MOLYBDENUM; NICKEL; OCCUPATIONAL EXPOSURE; PLATINUM;

EID: 33845696653     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772240601008513     Document Type: Review

References (345)

1. Evans UR. W. J. Müller's work and views on passivity. Chem. Ind. 1927;46:1219-1222.
2. Grogan CH, Oppenheimer H. Experimental studies in metal cancerigenesis. III. Behavior of chromium compounds in the physiological pH range. J. Am. Chem. Soc. 1955;77:152-157.
3. Mertz W. Chromium occurrence and function in biological systems. Physiol. Rev. 1969;49:163-239.
4. Committee on Biologic Effects of Atmospheric Pollutants. Medical and biologic effects of environmental pollutants: Chromium. Washington, DC: National Academy of Sciences; 1974.
5. Hayes RB. Cancer and occupational exposure to chromium chemicals. In: Lilienfeld AM, editor. Reviews of cancer epidemiology. Vol. 1. New York: Elsevier; 1979. pp 293-333.
6. Hamm RE, Johnson RL, Perkins RH, Davis RE. Complex ions of chromium. VIII. Mechanism of reaction of organic acid anions with chromium(III). J. Am. Chem. Soc. 1958;80:4469-4471.
7. Österberg R, Persson D, Bjursell G. The condensation of DNA by chromium(III) ions. J. Biomol. Struct. Dyn. 1984;2:285-290.
8. Wetterhahn KE, Hamilton JW, Aiyar J, Borges KM, Floyd R. Mechanism of chromium(VI) carcinogenesis. Biol. Trace Elem. Res. 1989;21:405-411.
9. Grogan CH. Experimental studies in metal cancerigenesis. VIII. On the etiological factor in chromate cancer. Cancer 1957;10:625-638.
10. Levis AG, Bianchi V, Tamino G, Pegoraro B. Cytotoxic effects of hexavalent and trivalent chromium on mammalian cells in vitro. Br. J. Cancer 1978;37:386-396.
11. Levis AG, Buttignol M, Bianchi V, Sponza G. Effects of potassium dichromate on nucleic acid and protein syntheses and on precursor uptake in BHK fibroblasts. Cancer Res. 1978b;38:110-116.
12. Hayes RB. The carcinogenicity of metals in humans. Cancer Causes Control 1997;38:371-385.
13. Norseth T. The carcinogenicity of chromium. Environ. Health Perspect. 1981;40:121-130.
14. Langård S. One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 1990;17:189-215.
15. Fletcher GG, Rossetto FE, Turnbull JD, Nieboer E. Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds. Environ. Health Perspect. 1994;102(Suppl. 3):69-79.
16. Toyokuni S. Iron-induced carcinogenesis: The role of redox regulation. Free Radic. Biol. Med. 1996;20:553-566.
17. Sutton HC, Winterbourn CC. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic. Biol. Med. 1989;6:53-60.
18. Magos L. Epidemiological and experimental aspects of metal carcinogenesis: Physicochemical properties, kinetics, and the active species. Environ. Health Perspect. 1991;95:157-189.
19. Jennette KW. The role of metals in carcinogenesis: Biochemistry and metabolism. Environ. Health Perspect. 1981;40:233-252.
20. Kazantzis G. Role of cobalt iron, lead, manganese, mercury, platinum, selenium, and titanium in carcinogenesis. Environ. Health Perspect. 1981;40:143-161.
21. IARC. Chromium, nickel and welding. IARC Monogr. Eval. Carcinog. Risks Hum. 1990;49:49-527.
22. IARC. Overall evaluation of carcinogenicity: An updating of IARC monographs volumes 1 to 42. IARC Monogr. Eval. Carcinog. Risks Hum. 1987;1-42(Suppl. 7):77-387.
23. IARC. Chlorinated drinking-water; chlorination by-products; some other halogenated compounds; cobalt and cobalt compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 1991;52:45-473.
24. IARC. Some antineoplastic and immunosuppressive agents. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1981;26:151-164.
25. Chan W-Y, Rennert OM. Genetic trace metal disturbances. J. Am. Coll. Nutr. 1985;4:39-48.
26. Dingwall A, Beans HT. Note on the detection and quantitative determination of chromium in tumors. Am. J. Cancer 1932;16:1499-1501.
27. Dingwall A, Beans HT. A spectrographic study of the occurrence of chromium and molybdenum in carcinoma of the human breast. Proc. Natl. Acad. Sci. USA 1934;20:416-420.
28. Dingwall A, Crosen RG, Beans HT. Studies on chromium. I. The quantitative determination of chromium in human tumors. Am. J. Cancer 1934;21:606-611.
29. Tietz NW, Hirsch EF, Neyman B. Spectrographic study of trace elements in cancerous and noncancerous human tissues. J. Am. Med. Assoc. 1957;165:2187-2192.
30. Williams MD, Sandler AB. The epidemiology of lung cancer. Cancer Treat. Res. 2001;105:31-52.
31. Schroeder HA, Balassa JJ, Tipton IH. Abnormal trace metals in man. Chromium. J. Chron. Dis. 1962;15:941-964.
32. Akslen LA, Myking AO, Mørkve O, Gulsvik A, Raithel HJ, Schaller KH. Increased content of chromium and nickel in lung tissues from patients with bronchial carcinoma. Path. Res. Pract. 1990;186:717-722.
33. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000;21:533-541.
34. Kondo K, Takahashi Y, Ishikawa S, Uchihara H, Hirose Y, Yoshizawa K, Tsuyuguchi M, Takizawa H, Miyoshi T, Sakiyama S, et al. Microscopic analysis of chromium accumulation in the bronchi and lung of chromate workers. Cancer 2003;98:2420-2429.
35. De Flora S, Badolati GS, Serra D, Picciotto A, Magnolia MR, Savarino V. Circadian reduction of chromium in the gastric environment. Mutat. Res. 1987;192:169-174.
36. De Flora S, Serra D, Camoirano A, Zanacchi P. Metabolic reduction of chromium, as related to its carcinogenic properties. Biol. Trace Elem. Res. 1989;21:179-187.
37. De Flora S, Camoirano A, Bagnasco M, Bennicelli C, Corbett GE, Kerger, BD. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 1997;18:531-537.
38. Costa M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit. Rev. Toxicol. 1997;27:431-442.
39. Alexeeff GV, Satin K, Painter P, Zeise L, Popejoy C, Murchison G. Chromium carcinogenicity: California strategies. Sci. Total Environ. 1989;86:159-168.
40. Stearns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J. 1995;15:1650-1657.
41. Christensen JM, Poulsen OM, Thomsen M. A short-term cross-over study on oral administration of soluble and insoluble cobalt compounds: Sex differences in biological levels. Int. Arch. Occup. Environ. Health 1993;65:233-240.
42. Christensen JM, Poulsen OM. A 1982-1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. Sci. Total Environ. 1994;150:95-104.
43. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N. Engl. J. Med. 1988;319:1047-1052.
44. Richmond HG. Induction of sarcoma in the rat by iron-dextran complex. Br. Med. J. 1959;1:947-949.
45. Herrmann H, Speck LB. Interaction of chromates with nucleic acids in tissues. Science 1954;119:221.
46. Denniston ML, Uyeki EM. Distribution and HPLC study of chromium-51 binding sites in Chinese hamster ovary cells. J. Toxicol. Environ. Health 1987;21:375-386.
47. Fornace Jr AJ, Seres DS, Lechner JF, Harris CC. DNA-protein cross-linking by chromium salts. Chem. Biol. Interact. 1981;36:345-354.
48. Wedrychowski A, Ward WS, Schmidt WN, Hnilica LS. Chromium-induced cross-linking of nuclear proteins and DNA. J. Biol. Chem. 1985;260:7150-7155.
49. Miller CA III, Costa M. Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate. Mol. Carcinogen. 1988;1:125-133.
50. Lin X, Zhuang Z, Costa M. Analysis of residual amino acid-DNA cross-links induced in intact cells by nickel and chromium compounds. Carcinogenesis 1992;13:1763-1768.
51. Voitkun V, Zhitkovich A, Costa M. Complexing of amino acids to DNA by chromate in intact cells. Environ. Health Perspect. 1994;102(Suppl. 3):251-255.
52. Persson D, Österberg R, Bjursell G. Mechanism of chromium carcinogenesis. Acta Toxicol. Pharmacol. 1986;59:260-263.
53. De Flora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat. Res. 1990;238:99-172.
54. Sirover MA, Loeb LA. Infidelity of DNA synthesis in vitro: Screening for potential metal mutagens or carcinogens. Science 1976;194:1434-1436.
55. Gruber JE, Jennette KW. Metabolism of the carcinogen chromate by rat liver microsomes. Biochem. Biophys. Res. Commun. 1978;82:700-706.
56. Heath JC, Webb M. Content and intracellular distribution of the inducing metal in the primary rhabdomyosarcomata induced in the rat by cobalt, nickel and cadmium. Br. J. Cancer 1967;21:768-779.
57. Costa M, Salnikow K, Cosentino S, Klein CB, Huang X, Zhuang Z. Molecular mechanisms of nickel carcinogenesis. Environ. Health Perspect. 1994;102(Suppl. 3):127-130.
58. Borochov N, Ausio J, Eisenberg H. Interaction and confirmational changes of chromatin with divalent ions. Nucleic Acids Res. 1984;12:3089-3096.
59. Patierno SR, Costa M. Effects of nickel(II) on nuclear protein binding to DNA in intact mammalian cells. Cancer Biochem. Biophys. 1987;9:113-126.
60. Becker FF. Keynote address: Evolution, chemical carcinogenesis, and mortality: The cycle of life. In: Griffin AC, Shaw CR, editors. Carcinogens: Identification and mechanisms of action. New York: Raven Press; 1979. pp 5-17.
61. Patierno SR, Sugiyama M, Basilion JB, Costa M. Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin. Cancer Res. 1985;45:5787-5794.
62. Ciccarelli RB, Wetterhahn KE. Nickel-bound chromatin, nucleic acids, and nuclear proteins from kidney and liver of rats treated with nickel carbonate in vivo. Cancer Res. 1984;44:3892-3897.
63. Misra M, Olinski R, Dizdaroglu M, Kasprzak KS. Enhancement by L-histidine of nickel(II)-induced DNA-protein cross-linking and oxidative DNA base damage in the rat kidney. Chem. Res. Toxicol. 1993;6:33-37.
64. Nieboer E, Tom RT, Rossetto FE. Superoxide dismutase activity and novel reactions with hydrogen peroxide of histidine-containing nickel(II)-oligopeptide complexes and nickel(II)-induced structural changes in synthetic DNA. Biol. Trace Elem. Res. 1989;21:23-33.
65. Kasprzak KS, Bal W, Karaczyn AA. The role of chromatin damage in nickel-induced carcinogenesis. A review of recent developments. J. Environ. Monit. 2003;5:183-187.
66. Ding M, Shi X. Molecular mechanisms of Cr(VI)-induced carcinogenesis. Mol. Cell. Biochem. 2002;234-235:293-300.
67. Lloyd DR, Phillips DH, Carmichael PL. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem. Res. Toxicol. 1997;10:393-400.
68. Rollinson CL. Chromium, molybdenum and tungsten. In: Bailar JC, Emeléus HJ, Nyholm R Sir, Trotman-Dickenson AF, editors. Comprehensive inorganic chemistry. Oxford: Pergamon Press; 1973. p 625, pp 737-738.
69. Goldschmidt VM. Geochemistry. Oxford: Clarendon Press; 1958.
70. Pauling L. The nature of the chemical bondIthaca. NY: Cornell University Press; 1940. p 93, p. 96.
71. Taube H. Mechanisms of redox reactions of simple chemistry. In: Emeléus HJ, Sharpe AG, editors. Advances in inorganic chemistry and radiochemistry. Vol. 1. New York: Academic Press; 1959. pp 25-27.
72. Taube H. Rates and mechanisms of substitution in inorganic complexes in solution. Chem. Rev. 1952;50:69-126.
73. Basolo F, Pearson RG. Mechanisms of inorganic reactions: A study of metal complexes in solution. New York: Wiley; 1967. pp 501-507.
74. Halpern J, Orgel LE. The theory of electron transfer between metal ions in bridged systems. Discuss. Faraday Soc. 1960;29:32-41.
75. Burlamacchi L, Martini G, Tiezzi E. Paramagnetic relaxation of hexacoordinated chromium(III) complexes with anionic ligands in aqueous solutions. J. Phys. Chem. 1970;74:1809-1812.
76. Gustavson KH. The chemistry of tanning processes. New York: Academic Press; 1956. pp 5-22, p 52; p 88, pp 94-96.
77. Thorstensen TC. Practical leather technology. Malabar: Robert E. Krieger; 1985. pp 118-146.
78. Bienkiewicz K. Physical chemistry of leather making. Malabar, FL: Robert E. Krieger; 1983. pp 348-352.
79. Lee JB. Elevated temperature potential-pH diagrams for the Cr-H2O, Ti-H2O, Mo-H2O, and Pt-H2O systems. Corrosion 1981;37:467-481.
80. O'Brien TJ, Ceryak S, Patierno SR. Complexities of chromium carcinogenesis: Role of cellular response, repair and recovery mechanisms. Mutat. Res. 2003;533:3-36.
81. Olatunji MA, McAuley A. Metal-ion oxidations in solution. Part XII. Oxidation of thioruea and NN′-ethylenethiourea by chromium(VI) in perchlorate media. J. Chem. Soc. Dalton Trans. 1975;682-688.
82. McCann JP, McAuley A. Metal-ion oxidations in solution. Part XIII. The reaction of chromium(VI) with L-cysteine in perchlorate media. J. Chem. Soc. Dalton Trans. 1975;783-790.
83. Bose RN, Mogghadas S, Gelerinter E. Long-lived chromium(IV) and chromium(V) metabolites in the chromium(VI)-glutathione reaction: NMR, ESR, HPLC, and kinetic characterization. Inorg. Chem. 1992;31:1987-1994.
84. Sugiura Y, Hojo Y, Tanaka H. Studies on the sulfur-containing chelating agents. XXXIII. Interaction of penicillamine and its related compounds with chromium ion and hemoglobin-bound chromium. Chem. Pharm. Bull. 1972;20:1362-1367.
85. Ogard AE, Taube H. Liability of Cr(IV) to substitution. J. Phys. Chem. 1958;62:357-358.
86. Hunt JP, Taube H. The exchange of water between hydrated cations and solvent. J. Chem. Phys. 1951;19:602-609.
87. Evans UR. A further survey of W. J. Müller's recent work on passivity. Part I. Chem. Ind. 1930;49:66-69.
88. Widom J, Baldwin RL. Monomolecular condensation of λ-DNA induced by cobalt hexammine. Biopolymers 1983;22:1595-1620.
89. 6. J. Mol. Biol. 1980;144:431-453.
90. Kortenkamp A, O'Brien P. Studies of the binding of chromium(III) complexes to phosphate groups of adenosine triphosphate. Carcinogenesis 1991;12:921-926.
91. Ding M, Shi X, Castranova V, Vallyathan V. Predisposing factors in occupational lung cancer: Inorganic minerals and chromium. J. Environ. Pathol. Toxicol. Oncol. 2000;19:129-138.
92. 4 mediates cellular responses via reactive oxygen species. Mol. Cell. Biochem. 2004;255:171-179.
93. Küntzel A, Erdman H, Spahrkas H. Formation of simple masked chromium complexes. VI. The constitution of organic masked chrome compounds (chromium formate, acetate and oxalate) (abstract). J. Am. Leather Chemists Assoc. 1954;49:118-120.
94. Theis ER, Weidner CL. Studies in chrome liquors. VI. A critical study of the reduction of potassium dichromate by sucrose. J. Am. Leather Chemists Assoc. 1937;32:424-459.
95. Clark JH. The denaturation of proteins by chromium salts. A.M.A. Arch. Ind. Health 1959;20:117-123.
96. Gentile JM, Hyde K, Schubert J. Chromium genotoxicity as influenced by complexation and rate effects. Toxicol. Lett. 1981;7:439-448.
97. Lanfranchi G, Paglialunga S, Levis AG. Mammalian cell transformation induced by chromium(VI) compounds in the presence of nitrilotriacetic acid. J. Toxicol. Environ. Health 1988;24:251-260.
98. Gould ES, Taube H. Electron transfer through organic structural units. Aromatic and heterocyclic carboxylates as bridging groups in oxidation-reduction reactions. J. Am. Chem. Soc. 1964;86:1318-1328.
99. Gould ES. Electron transfer through organic structural units. II. Conjugated and reducible ligands as bridging groups in oxidation-reduction reactions. J. Am. Chem. Soc. 1965;87:4730-4740.
100. Huchital DH, Taube H. Ester hydrolysis in the reaction of methyl and ethylmalonatopentaamminecobalt(III) complexes. J. Am. Chem. Soc. 1965;87:5371-5377.
101. Vineis P, Magnani C. Occupation and bladder cancer in males: A case-control study. Int. J. Cancer 1985;35:599-606.
102. Cole P, Hoover R, Friedell GH. Occupation and cancer of the lower urinary tract. Cancer 1972;29:1250-1260.
103. Some industrial chemicals. IARC. Some Industrial; Monogr. Eval. Carcinog. Risks Hum. 2000;77:503-529.
104. Sorahan T, Hamilton L, Wallace DM, Bathers S, Gardiner K, Harrington JM. Occupational urothelial tumours: A regional case-control study. Br. J. Urol. 1998;82:25-32.
105. Decoufle P. Cancer risks associated with employment in the leather and leather products industry. Arch. Environ. Health 1979;34:33-37.
106. Irving CC. Species and tissue variations in the metabolic activation of aromatic amines. In: Griffin AC, Shaw CR, editors. Carcinogens: Identification and mechanisms of action. New York: Raven Press; 1979. pp 211-227.
107. Theis ER, Serfass EJ. Studies in chrome liquors. A study of sucrose reduced liquors. J. Am. Leather Chemists Assoc. 1934;29:431-461.
108. Gmelin. Chrom. A. In: Meyer RJ, Pietsch EHE, Kotowski A, editors. Gmelins Handbuch der Anorganischen Chemie, Vol. 2, "Reduktion von Chrom(VI) zu Chrom(III) (oder Chrom(IV))," pp 680-702;
109. "Oxydation von Chrom(III) zu Chrom(VI)," pp 676-680. Weinheim: Verlag Chemie; 1963.
110. Wagner C. Über den Nachweis von Zwischenprodukten bei Oxydationen durch Chromsäure. Z. Anorg. Allg. Chem. 1928;168:279-291.
111. Branca M, Dessi A, Kozlowski H, Micera G, Serra MV. In vitro interaction of mutagenic chromium(VI) with red blood cells. FEBS Lett. 1989;257:52-54.
112. Kortenkamp A, O'Brien P. The generation of DNA single-strand breaks during the reduction of chromate by ascorbic acid and/or glutathione in vitro. Environ. Health Perspect. 1994;102(Suppl. 3):237-241.
113. Smith WL, Gadd GM. Reduction and precipitation of chromate by mixed-culture sulphate-reducing bacterial biofilms. J. Appl. Microbiol. 2000;88:983-991.
114. Boyland E. Some chemical constituents and biochemical reactions of tumours. Acta Unio Int. Contra Cancrum 1938;3:3-10.
115. La Vecchia C, Franceschi S, Dolara P, Bidoli E, Barbone F. Refined- sugar intake and the risk of colorectal cancer in humans. Int. J. Cancer 1993;55:386-389.
116. De Stefani E, Deneo Pellegrini H, Mendilaharsu M, Ronco A, Carzoglio JC. Dietary sugar and lung cancer: A case-control study in Uruguay. Nutr. Cancer 1998;31:132-137.
117. Willett W. The search for the causes of breast and colon cancer. Nature 1989;338:389-394.
118. Venier P, Montaldi A, Majone F, Bianchi V, Levis AG. Cytotoxic, mutagenic and clastogenic effects of industrial chromium compounds. Carcinogenesis 1982;3:1331-1338.
119. Venier P, Montaldi A, Busi L, Gava C, Zentilin L, Tecchio G, Bianchi V, Levis AG. Genetic effects of chromium tannins. Carcinogenesis 1985;6:1327-1335.
120. Elias Z, Schneider O, Aubry F, Daniere MC, Poirot O. Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide. Carcinogenesis 1983;4:605-611.
121. Manusco TF, Hueper WC. Occupational cancer and other health hazards in a chromate plant: A medical appraisal. I. Lung cancers in chromate workers. Ind. Med. Surg. 1951;20:358-363.
122. Gmelin. Chrom. B. In: Meyer RJ, Pietsch EHE, Kotowski A, editors. Gmelins Handbuch der Anorganischen Chemie, "Chrom(III)-Oxid," Weinheim: Verlag Chemie; 1963. p. 38.
123. Lewis Sr RJ, editor. Hawley's condensed chemical dictionary. New York: Van Nostrand Reinhold; 1993.
124. Wood, leather and some associated industries. IARC. Some Metals and Monogr. Eval. Carcinog. Risk Chem. Hum. 1981;25:49-379.
125. Some metals and metallic compounds. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1980;23:205-323.
126. Merritt K, Brown SA. Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J. Biomed. Mater. Res. 1995;29:627-633.
127. Petrilli FL, De Flora S. Oxidation of inactive trivalent chromium to the mutagenic hexavalent form. Mutat. Res. 1978;58:167-173.
128. Arslan P, Beltrame M, Tomasi A. Intracellular chromium reduction. Biochim. Biophys. Acta 1987;931:10-15.
129. Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B. Sources, pathways, and relative risks of contaminants in surfac water and groundwater: A perspective prepared for the Walkerton inquiry. J. Toxicol. Environ. Health Part A 2002;65:1-142.
130. Ohnishi S, Murata M, Kawanishi S. DNA damage induced by hypochlorite and hypobromite with reference to inflammation-associated carcinogenesis. Cancer Lett. 2002;178:37-42.
131. Müller WJ. Über die Passivität der Metalle, speziell des Eisens. Z. Elektrochem. 1924;30:401-416.
132. Evans UR. A further survey of W. J. Müller's recent work on passivity. Part II. Chem. Ind. 1930;49:92-93.
133. Kolotyrkin JM, Bune NJ. Das elekrochemische Verhalten von Nickel in Schwefelsäure in Anwesenheit verschiedener Oxydationsmittel. Z. Phys. Chem. 1960;213:264-279.
134. Berg TGO. Die Lösungsgeschwindigkeit von Molybdän in Salpetersäure bei 25°. Z. Anorg. Allg. Chem. 1952;269:117-119.
135. Evans UR. The passivity of metals. Part I. The isolation of the protective film. J. Chem. Soc. 1927;1:1020-1040.
136. Latimer WM. The oxidation states of the elements and their potentials in aqueous solution. New York: Prentice-Hall; 1952.
137. +4 2 and its formation by oxygen oxidation of chromous solutions. Inorg. Chem. 1964;3:322-324.
138. Black J. Metallic ion release and its relationship to oncogenesis. In: Fitzgerald Jr RH, editor. The Hip: Proceedings of the thirteenth open scientific meeting of the Hip Society, 1985, St. Louis: CV Mosby; 1985. pp 199-213.
139. Brown SA, Zhang K, Merritt K, Payer JH. In vivo transport and excretion of corrosion products from accelerated anodic corrosion of porous coated F75 alloy. J. Biomed. Mater. Res. 1993;27:1007-1017.
140. Howie DW, Rogers SD, McGee MA, Hayes DR. Biologic effects of cobalt chrome in cell and animal models. Clin. Orthop. 1996;329(Suppl.):217-232.
141. Surgical implants and other foreign bodies. IARC. Surgical Implants Monogr. Eval. Carcinog. Risks Hum. 1999;74:35-376.
142. Strehblow HH, Wenners J. Investigation of the processes on iron and nickel electrodes at high corrosion current densities in solutions of high chloride content. Electrochim. Acta 1977;22:421-427.
143. Strehblow HH, Titze B, Löchel BP. The breakdown of passivity of iron and nickel by fluoride. Corrosion Sci. 1979;19:1047-1057.
144. Strehblow HH, Löchel BP. Breakdown of passivity of iron and nickel by fluoride. In: Froment M, editor. Passivity of metals and semiconductors. Amsterdam: Elsevier; 1983. pp 397-386.
145. Willert H-G, Brobäck L-G, Buchhorn GH, Jensen PH, Köster G, Lang I, Ochsner P, Schenk R. Crevice corrosion of cemented titanium alloy stems in total hip replacements. Clin. Orthop. 1996;333:51-75.
146. Royle H. Toxicity of chromic acid in the chromium plating industry. Environ. Res. 1975;10:39-53.
147. Waterhouse JAH. Cancer among chromium platers (abstract). Br. J. Cancer 1975;32:262.
148. Sorahan T, Burges DCL, Waterhouse JAH. A mortality study of nickel/chromium platers. Br. J. Ind. Med. 1987;44:250-258.
149. Burges DC. Mortality study of nickel platers. In: Brown SS, Sunderman FW, editors. Nickel toxicology. London: Academic Press; 1980. pp 15-18.
150. Barborik M. The problem of harmful exposures to chromium compounds. Ind. Med. 1970;39:221-224.
151. Tisch M, Maier H. Plattenepithelkarzinom der Zunge nach beruflicher Exposition gegenüber Chrom-VI-Verbindungen. Laryngo-Rhino-Otol. 1996;75:455-458.
152. Cookfair DL, Wende KE, Michalek AM, Vena JE. A case-control study of laryngeal cancer among workers exposed to sulfuric acid (abstract). Am. J. Epidemiol. 1985;122:521.
153. Soskolne CL, Zeighami EA, Hanis NM, Kupper LL, Herrmann N, Amsel J, Mausner JS, Stellman JM. Laryngeal cancer and occupational exposure to sulfuric acid. Am. J. Epidemiol. 1984;120:358-369.
154. Beaumont JJ, Leveton J, Knox K, Bloom T, McQuiston T, Young M, Goldsmith R, Steenland NK, Brown DP, Halperin WE. Lung cancer mortality in workers exposed to sulfuric acid mist and other acid mists. J. Natl. Cancer Inst. 1987;79:911-921.
155. IARC. Occupational exposures to mists and vapours from strong inorganic acids; and other industrial chemicals. IARC Monogr. Eval. Carcinog. Risks Hum. 1992;54:41-130.
156. Treon JF, Dutra FR, Cappel J, Sigmon H, Younker W. Toxicity of sulfuric acid mist. A.M.A. Arch. Ind. Hyg. Occup. Med. 1950;2:716-734.
157. 2. Br. J. Cancer 1967;21:606-618.
158. Folinsbee LJ. Human health effects of exposure to airborne acids. Environ. Health Perspect. 1989;79:195-199.
159. Soskolne CL, Pagano G, Cipollaro M, Beaumont JJ, Giordano GG. Epidemiologic and toxicologic evidence for chronic health effects and the underlying biologic mechanisms involved in sub-lethal exposures to acidic pollutants. Arch. Environ. Health 1989;44:180-191.
160. Schlatter C. Speculations on mechanisms of metal carcinogenesis. Toxicol. Environ. Chem. 1984;9:127-137.
161. Feron VJ, Arts JHE, Kuper CF, Slootweg PJ, Woutersen RA. Health risks associated with inhaled nasal toxicants. Crit. Rev. Toxicol. 2001;31:313-347.
162. Winchester JW. Sulfur, aerosols, and acid rain in the Eastern United States. In: Schwartz SE, editor. Trace atmospheric constituents: Properties, transformations, and fates. NewYork: Wiley; 1983. pp 269-301.
163. Blot WJ, Davies JE, Brown LM, Nordwall CW, Buiatti E, Ng A, Fraumeni Jr JF. Occupation and the high risk of cancer in northeast Florida. Cancer 1982;50:364-371.
164. Babich H, Davis LD, Stotzky G. Acid precipitation - causes and consequences. Environment 1980;22:6-13, 40-41.
165. Bond GG, Flores GH, Stafford BA, Olsen GW. Lung cancer and hydrogen chloride exposure: Results from a nested case-control study of chemical workers. J. Occup. Med. 1991;33:958-961.
166. Bond GG, Flores GH, Shellenberger RJ, Cartmill JB, Fishbeck WA, Cook RR. Nested case control-study of lung cancer among chemical workers. Am. J. Epidemiol. 1986;124:53-66.
167. Bond GG, Shellenberger RJ, Fishbeck WA, Cartmill JB, Lasich BJ, Wymer KT, Cook RR. Mortality among a large cohort of chemical manufacturing employees. J. Natl. Cancer Inst. 1985;75:859-869.
168. Lesko SA, Drocourt J-L, Yang S-U. Deoxyribonucleic acid-protein and deoxyribonucleic acid interstrand cross-links induced in isolated chromatin by hydrogen peroxide and ferrous ethylenediaminetetraacetate chelates. Biochemistry 1982;21:5010-5015.
169. Neta P, Huie RE. Free-radical chemistry of sulfite. Environ. Health Perspect. 1985;64:209-217.
170. Huie RE, Peterson NC. Reactions of sulfur(IV) with transition-metal ions in aqueous solutions. In: Schwartz SE, editor. Trace atmospheric constituents: Properties, transformations, and fates. New York: Wiley; 1983.
171. Alwens W, Jonas W. Der Chromat-Lungenkrebs. Acta Unio Int. Contra. Cancrum. 1938;3:103-114.
172. Bidstrup PL, Case RAM. Carcinoma of the lung in workmen in the bichromates-producing industry in Great Britain. Br. J. Ind. Med. 1956;13:260-264.
173. Rosenman KD, Stanbury M. Risk of lung cancer among former chromium smelter workers. Am. J. Ind. Med. 1996;29:491-500.
174. Korallus U, Lange H-J, Neiss A, Wüstefeld E, Zwingers T. Zusammenhänge zwischen Sanierungsmaßnahmen und Bronchialkarzinommortalität in der chromatherstellenden Industrie. Arbeitsmed. Sozialmed. Präventivmed. 1982;17:159-167.
175. Davies J. Lung-cancer mortality of workers making chrome pigments (Letter). Lancet 1978;1:384.
176. Sheffet A, Thind I, Miller AM, Louria DB. Cancer mortality in a pigment plant utilizing lead and zinc chromates. Arch. Environ. Health 1982;37:44-52.
177. Stern FB, Beaumont JJ, Halperin WE, Murthy LI, Hills BW, Fajen JM. Mortality of chrome leather tannery workers and chemical exposures in tanneries. Scand. J. Work Environ. Health 1987;13:108-117.
178. Seniori Costantini A, Paci E, Miligi L, Buiatti E, Martelli C, Lenzi S. Cancer mortality among workers in the Tuscan tanning industry. Br. J. Ind. Med. 1989;46:384-388.
179. Montanaro F, Ceppi M, Demers PA, Puntoni R, Bonassi S. Mortality in a cohort of tannery workers. Occup. Environ. Med. 1997;54:588-591.
180. Garabrant DH, Wegman DH. Cancer mortality among shoe and leather workers in Massachusetts. Am. J. Ind. Med. 1984;5:303-314.
181. Sweeney MH, Walrath J, Waxweiler RJ. Mortality among retired fur workers. Dyers, dressers (tanners) and service workers. Scand. J. Work Environ. Health 1985;11:257-264.
182. Marrett LD, Hartge P, Meigs JW. Bladder cancer and occupational exposure to leather. Br. J. Ind. Med. 1986;43:96-100.
183. Acheson ED, Cowdell RH, Jolles B. Nasal cancer in the Northamptonshire boot and shoe industry. Br. Med. J. 1970;1:385-393.
184. Acheson ED. Nasal cancer in the furniture and boot and shoe manufacturing industries. Prev. Med. 1976;5:295-315.
185. Pippard EC, Acheson ED, Winter PD. Mortality of tanners. Br. J. Ind. Med. 1985;42:285-287.
186. Acheson ED, Cowdell RH, Rang EH. Nasal cancer in England and Wales: An occupational survey. Br. J. Ind. Med. 1981;38:218-224.
187. Coggon D, Pannett B, Osmond C, Acheson ED. A survey of cancer and occupation in young and middle aged men. I. Cancers of the respiratory tract. Br. J. Ind. Med. 1986;43:332-338.
188. Malker HR, Malker BK, McLaughlin JK, Blot WJ. Kidney cancer among leather workers. Lancet 1984;1:56.
189. Edling C, Kling H, Flodin U, Axelson O. Cancer mortality among leather tanners. Br. J. Ind. Med. 1986;43:494-496.
190. Mikoczy Z, Schutz A, Hagmar L. Cancer incidence and mortality among Swedish leather tanners. Occup. Environ. Med. 1994;51:530-535.
191. Iaia TE, Bartoli D, Calzoni P, Comba P, De Santis M, Dini F, Ercolanelli M, Farina GA, Pirastu R, Seniori Costantini A, et al. Cohort study of mortality among leather tanners in the Lower Valdarno area. Med. Lav. 2002;93:95-107.
192. Sugiyama M, Tsuzuki K, Ogura R. Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate(VI). J. Biol. Chem. 1991;266:3383-3386.
193. 2-enhancement of sodium chromate (VI)-induced DNA single strand breaks: ESR study of the action of vitamin B2. Biochem. Biophys. Res. Commun. 1989;159:1080-1085.
194. 2 in Chinese hamster V79 cells. Mutat. Res. 1992;283:211-214.
195. IARC. Wood dust and formaldehyde. IARC Monogr. Eval. Carcinog. Risks Hum. 1995;62:35-215.
196. Kauppinen T. Occupational exposure to chemical agents in the plywood industry. Ann. Occup. Hyg. 1986;30:19-29.
197. Kauppinen TP, Partanen TJ, Nurminen MM, Nickels JI, Hernberg SG, Hakulinen TR, Pukkala EI, Savonen ET. Respiratory cancers and chemical exposures in the wood industry: A nested case-control study. Br. J. Ind. Med. 1986;43:84-90.
198. IARC. Man-made mineral fibres and radon. IARC Monogr. Eval. Carcinog. Risks Hum. 1988;43:39-171.
199. IARC. Silica, some silicates, coal dust and para-aramid fibrils. IARC Monogr. Eval. Carcinog. Risks Hum. 1997;68:41-242.
200. Fu H, Demers PA, Seniori Costantini A, Winter P, Colin D, Kogevinas M, Boffetta P. Cancer mortality among shoe manufacturing workers: An analysis of two cohorts. Occup. Environ. Med. 1996;53:394-398.
201. Cecchi F, Buiatti E, Kriebel D, Nastasi L, Santucci M. Adenocarcinoma of the nose and paranasal sinuses in shoemakers and woodworkers in the province of Florence, Italy (1963-77). Br. J. Ind. Med. 1980;37:222-225.
202. Merler E, Baldasseroni A, Laria R, Faravelli P, Agostini R, Pisa R, Berrino F. On the causal association between exposure to leather dust and nasal cancer: Further evidence from a case-control study. Br. J. Ind. Med. 1986;43:91-95.
203. Comba P, Barbieri PG, Battista G, Belli S, Ponterio F, Zanetti D, Axelson O. Cancer of the nose and paranasal sinuses in the metal industry: A case-control study. Br. J. Ind. Med. 1992;49:193-196.
204. Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand. J. Work Environ. Health
205. Schoental R. Chromium carcinogenesis, formation of epoxyaldehydes and tanning. (Letter) Br. J. Cancer 1975;32:403-404.
206. Roush GC, Meigs JW, Kelly J, Flannery JT, Burdo H. Sinonasal cancer and occupation: A case-control study. Am. J. Epidemiol. 1980;111:183-193.
207. Viadana E, Bross IDJ, Houten L. Cancer experience of men exposed to inhalation of chemicals or to combustion products. J. Occup. Med. 1976;18:787-792.
208. Brinton L, Blut WJ, Becker JA, Winn DM, Browder JP, Farmer Jr JC, Fraumeni Jr JF. A case control study of cancers of the nasal cavity and paranasal sinuses. Am. J. Epidemiol. 1984;119:896-906.
209. Magnani C, Comba P, Ferraris F, Ivaldi C, Meneghin M, Terracini B. A case-control study of carcinomas of the nose and paranasal sinuses in the woolen textile manufacturing industry. Arch. Environ. Health 1993;48:94-97.
210. Sesana G, Cortona G, Baj A, Quaianni T, Colombo E. Cobalt exposure in wet grinding of hard metal tools for wood manufacture. Sci. Total Environ. 1994;150:117-119.
211. Lauwerys R, Lison D. Health risks associated with cobalt exposure - An overview. Sci. Total Environ. 1994;150:1-6.
212. Lison D, De Boeck M, Verougstraete V, Kirsch-Volders M. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup. Environ. Med. 2001;58:619-625.
213. Pott F, Ziem U, Reiffer F-J, Huth F, Ernst H, Mohr U. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp. Pathol. 1987;32:129-152.
214. Cralley LJ. Electromotive phenomenon in metal and mineral particulate exposures: Relevance to exposure to asbestos and occurrence of cancer. Am. Ind. Hyg. Assoc. J. 1971;32:653-661.
215. Furst A, Haro RT. A survey of metal carcinogenesis. Prog. Exp. Tumor Res. 1969;12:102-133.
216. IARC. Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 1976;11:75-112.
217. Marcus P, Oudar J. Passivation of nickel-iron alloys. Influence of sulphur. In: Froment M, editor. Passivity of metals and semiconductors. Amsterdam: Elsevier; 1983. pp 119-124.
218. Boldt Jr JR. In: Queneau P, editor. The winning of nickel. Its geology, mining, and extractive metallurgy. Princeton: Van Nostrand; 1967. pp 374-380, p 381, pp 355-361, p 389.
219. Oudar J, Marcus P. Role of adsorbed sulphur in the dissolution and passivation of nickel and nickel-sulphur alloys. Appl. Surf. Sci. 1979;3:48-67.
220. Sunderman Jr FW. Recent research on nickel carcinogenesis. Environ. Health Perspect. 1981;40:131-141.
221. Costa M. Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 1991;31:321-327.
222. Costa M. Model for the epigenetic mechanism of action of nongenotoxic carcinogens. Am. J. Clin. Nutr. 1995;61(Suppl.):666-669.
223. Oskarsson A, Andersson Y, Tjälve H. Fate of nickel subsulfide during carcinogenesis studied by autoradiography and x-ray power defraction. Cancer Res. 1979;39:4175-4182.
224. Vetter KJ, Arnold K. Korrosion und Sauerstoffüberspannung des passiven Nickels in Schwefelsäure. Z. Elektrochem. 1960;64:244-251.
225. El Wakkad SES, Emara SH. The anodic oxidation of metals at very low current density. Part II. Nickel. J. Chem. Soc. 1953;Part 4:3504-3508.
226. Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: An in vitro study in rats. Neurosci. Lett. 1999;261:21-24.
227. Lewis JG, Adams DO. Inflammation, oxidative DNA damage, and carcinogenesis. Environ. Health Perspect. 1987;76:19-27.
228. 2 formation by human polymorphonuclearleukocytes. Cancer Res. 1990;50:7564-7570.
229. Youngblood MP, Margerum DW. Reaction entropies of copper(III,II) peptide and nickel(III,II) peptide redox couples and the role of axial solvent coordination. Inorg. Chem. 1980;19:3068-3072.
230. Reid TM, Feig DI, Loeb LA. Mutagenesis by metal-induced oxygen radicals. Environ. Health Perspect. 1994;102(Suppl. 3):57-61.
231. Murray CK, Margerum DW. Electron-transfer kinetics between deprotonated-peptide complexes of nickel(III) and nickel(II). Inorg. Chem. 1983;22:463-469.
232. Margerum DW, Anliker SL. Nickel(III) chemistry and properties of the peptide complexes of Ni(II), and Ni(III). In: Lancaster Jr JR, editor. The bioinorganic chemistry of nickel. New York: VCH Publishers; 1988. pp 29-51.
233. Higinbotham KG, Rice JM, Diwan BA, Kasprzak KS, Reed CD, Perantoni AO. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res. 1992;52:4747-4751.
234. Sunderman Jr FW, Lau TJ, Cralley LJ. Inhibitory effect of manganese upon muscle tumorigenesis by nickel subsulfide. Cancer Res. 1974;34:92-95.
235. Sunderman Jr FW, Kasprzak KS, Lau TJ, Minghetti PP, Maenza RM, Becker N, Onkelinx C, Goldblatt PJ. Effects of manganese on carcinogenicity and metabolism of nickel subsulfide. Cancer Res. 1976;36:1790-1800.
236. Sunderman Jr FW, McCully KS. Effects of manganese compounds on carcinogenicity of nickel subsulfide in rats. Carcinogenesis 1983;4:461-465.
237. Kasprzak KS, Sunderman Jr FW. Mechanisms of dissolution of nickel subsulfide in rat serum. Res. Commun. Chem. Path. Pharmacol. 1977;16:95-108.
238. Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am. J. Ind. Med. 1996;29:474-490.
239. Doll R. Cancer of the lung and nose in nickel workers. Br. J. Ind. Med. 1958;15:217-223.
240. Doll R. Occupational lung cancer: A review. Br. J. Ind. Med. 1959;16:181-190.
241. Mond L, Langer C, Quincke F. Action of carbon monoxide on nickel. J. Chem. Soc. 1890;57:749-753.
242. Mond L. The history of my process of nickel extraction. J. Soc. Chem. Ind. 1895;14:945-946.
243. Morgan GL. Some observations on the incidence of respiratory cancer in nickel workers. Br. J. Ind. Med. 1958;15:224-234.
244. Doll R, Morgan LG, Speizer F. Cancers of the lung and nasal sinuses in nickel workers. Br. J. Cancer 1970;24:623-632.
245. Doll R, Mathews JG, Morgan LJ. Cancer of the lung and nasal sinuses in nickel workers: A reassessment of the period risk. Br. J. Ind. Med. 1977;34:102-105.
246. Sunderman Jr FW. A review of the metabolism and toxicology of nickel. Ann. Clin. Lab. Sci. 1977;7:377-398.
247. Sunderman Jr FW, Donnelly AJ. Studies of nickel carcinogenesis: Metastasizing pulmonary tumors in rats induced by inhalation of nickel carbonyl. Am. J. Pathol. 1965;46:1027-1042.
248. Raithel H-J, Schaller KH. Zur Toxizität und Kanzerogenität von Nickel und seinen Verbindungen. Eine Übersicht zum derzeitigen Erkenntnisstand. Zbl. Bakt. Hyg. I. Abt. Orig. B 1981;173:63-91.
249. Williams WJ. The pathology of the lungs in five nickel workers. Br. J. Ind. Med. 1958;15:235-242.
250. Easton DF, Peto J, Morgan LG, Metcalfe LP, Usher V, Doll R. Respiratory cancer mortality in Welsh nickel refiners: Which nickel compounds are responsible? In: Nieboer E, Nriagu JO, editors. Nickel and human health. Current perspectives, Advances in environmental science and technology. Vol. 25. New York: Wiley; 1992. pp 603-619.
251. Mastromatteo E. Nickel: A review of its occupational health aspects. J. Occup. Med. 1967;9:127-136.
252. Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ. Health Perspect. 1994;102(Suppl. 1):275-282.
253. Høgetveit AC, Barton RT. Preventive health program for nickel workers. J. Occup. Med. 1976;18:805-808.
254. Grimsrud TK, Berge SR, Resmann F, Norseth T, Andersen A. Assessment of historical exposures in a nickel refinery in Norway. Scand. J. Work Environ. Health 2000;26:338-345.
255. Grimsrud TK, Berge SR, Martinsen JI, Andersen A. Lung cancer incidence among Norwegian nickelrefinery workers 1953-2000. J. Environ. Monit. 2003;5:190-197.
256. Solberg LA, Torjussen W. Histological changes in nasal mucosa of workers in an electrolytic nickel refinery (abstract). Ann. Clin. Lab. Sci. 1978;8:503.
257. Pedersen E, Høgetveit AC, Andersen A. Cancer of the respiratory organs among workers at a nickel factory in Norway. Int. J. Cancer 1973;12:32-41.
258. Pedersen E, Andersen A, Høgetveit A. Second study of the incidence and mortality of cancer of respiratory organs among workers at a nickel refinery (abstract). Ann. Clin. Lab. Sci. 1978;8:503-504.
259. Magnus K, Andersen A, Høgetveit AC. Cancer of respiratory organs among workers at a nickel refinery in Norway. Second report. Int. J. Cancer 1982;30:681-685.
260. Grimsrud TK, Berge SR, Haldorsen T, Andersen A. Exposure to different forms of nickel and risk of lung cancer. Am. J. Epidemiol. 2002;156:1123-1132.
261. Enterline PE, Marsh GM. Mortality among workers in a nickel refinery and alloy manufacturing plant in West Virginia. J. Natl. Cancer Inst. 1982;68:925-933.
262. Glaumann H, Jansson H, Arborgh B, Ericsson JLE. Isolation of liver lysosomes by iron loading: Ultrastructural characterization. J. Cell. Biol. 1975;67:887-894.
263. Sykes AG. Further advances in the study of mechanisms of redox reactions. In: Emeléus HJ, Sharpe AG, editors. Advances in inorganic chemistry and radiochemistry. Vol. 10. New York: Academic Press; 1967. pp 153-245.
264. Nicholls D. Iron. In: Bailar JC, Emeléus HJ, Nyholm R Sir, Trotman-Dickenson AF, editors. Comprehensive inorganic chemistry. Oxford: Pergamon Press; 1973. p 1006.
265. Kon SH. Biological autoxidation. I. Decontrolled iron: An ultimate carcinogen and toxicant: An hypothesis. Med. Hypotheses 1978;4:445-471.
266. Hilger I, Andrä W, Hergt R, Hiergeist R, Schubert H, Kaiser WA. Electromagnetic heating of breast tumors in interventional radiology: In vitro and in vivo studies in human cadavers and mice. Radiology 2001;218:570-575.
267. Macklis RM. Magnetic healing, quackery, and the debate about the health effects of electromagnetic fields. Ann. Intern. Med. 1993;118:376-383.
268. Remsen LG, McCormick CI, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellström KE, Hellström I, Kroll RA, Neuwelt EA. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis. AJNR Am. J. Neuroradiol. 1996;17:411-418.
269. Liu M, Okada S. Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N′-diacetate. Carcinogenesis 1994;15:2817-2821.
270. Nackerdien Z, Rao G, Cacciuttolo MA, Gajewski E, Dizdaroglu M. Chemical nature of DNA-protein crosslinks produced in mammalian chromatin by hydrogen peroxide in the presence of iron or copper ions. Biochemistry 1991;30:4873-4879.
271. Mandelkern M, Dattagupta N, Crothers DM. Conversion of B DNA between solution and fiber conformations. Proc. Natl. Acad. Sci. USA 1981;78:4294-4298.
272. Altman SA, Zastawny TH, Randers-Eichhorn L, Cacciuttolo MA, Akman SA, Dizdaroglu M, Rao G. Formation of DNA-protein cross-links in cultured mammalian cells upon treatment with iron ions. Free Radic. Biol. Med. 1995;19:897-902.
273. Conte D, Narindrasorasak S, Sarkar B. In vivo and in vitro iron-replaced zinc finger generates free radicals and causes DNA damage. J. Biol. Chem. 1996;271:5125-5130.
274. Laires A, Borba H, Rueff J, Goes MI, Halpern M. Urinary mutagenicity in occupational exposure to mineral oils and iron oxide particles. Carcinogenesis 1982;3:1077-1079.
275. Perera FP, Dickey C, Santella R, O'Neill JP, Albertini RJ, Ottman R, Tsai WY, Mooney LA, Savela K, Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis 1994;15:2905-2910.
276. Wacker WEC, Vallee BL. Nucleic acids and metals. I. Chromium, manganese, nickel, iron, and other metals in ribonucleic acid from diverse biological sources. J. Biol. Chem. 1959;234:3257-3262.
277. Henry MC, Port CD, Kaufman DG. Importance of physical properties of benzo[a]pyrene-ferric oxide mixtures in lung tumor induction. Cancer Res. 1975;35:207-217.
278. Steinhoff D, Mohr U, Hahnemann S. Carcinogenesis studies with iron oxides. Exp. Pathol. 1991;43:189-194.
279. Antonini JM, Taylor MD, Zimmer AT, Roberts JR. Pulmonary responses to welding fumes: Role of metal constituents. J. Toxicol. Environ. Health Part A 2003;67:233-249.
280. Stern RM. Assessment of risk of lung cancer for welders. Arch. Environ. Health 1983;38:148-155.
281. Matczak W, Chmielnicka J. Relation between various chromium compounds and some other elements in fumes from manual metal arc stainless steel welding. Br. J. Ind. Med. 1993;50:244-251.
282. Danielson E, Langård S, Andersen A, Knudsen Ø. Incidence of cancer among welders of mild steel and other shipyard workers. Br. J. Ind. Med. 1993;50:1097-1103.
283. Danielson E, Langård S, Andersen A. Incidence of cancer among welders and other shipyard workers with information on previous work history. J. Occup. Environ. Med. 2000;42:101-109.
284. Moulin JJ, Wild P, Haguenoer JM, Faucon D, De Gaudemaris R, Mur JM, Mereau M, Gary Y, Toamain JP, Birembaut Y, et al. A mortality study among mild steel and stainless steel welders. Br. J. Ind. Med. 1993;50:234-243.
285. Hansen KS, Lauritsen JM, Skytthe A. Cancer incidence among mild steel and stainless steel welders and other metal workers. Am. J. Ind. Med. 1996;30:373-382.
286. Lauritsen JM, Hansen KS. Lung cancer mortality in stainless steel and mild steel welders: A nested casereferent study. Am. J. Ind. Med. 1996;30:383-391.
287. Beaumont JJ, Weiss NS. Lung cancer among welders. J. Occup. Med. 1981;23:839-844.
288. Leira HL, Lund E, Refseth T. Mortality and cancer incidence in a small cohort of miners exposed to low levels of α radiation. Health Phys. 1986;50:189-194.
289. Edling C. Lung cancer and smoking in a group of iron ore miners. Am. J. Ind. Med. 1982;3:191-199.
290. Harty LC, Guinee Jr DG, Travis WD, Bennett WP, Jett J, Colby TV, Taazelar H, Trastek V, Pairolero P, Liotta LA, et al. p53 mutations and occupational exposures in a surgical series of lung cancers. Cancer Epidemiol. Biomarkers Prev. 1996;5:997-1003.
291. Meyers CR, Meyers JM. Iron stimulates the rate of reduction of hexavalent chromium by human microsomes. Carcinogenesis 1998;19:1029-1038.
292. El Wakkad SES, Emara SH. The anodic oxidation of metals at very low current density. Part III. Copper. J. Chem. Soc. 1953;Part 4:3508-3512.
293. Gilman JPW. Metal carcinogenesis. II. A study on the carcinogenic activity of cobalt, copper, iron and nickel compounds. Cancer Res. 1962;22:158-162.
294. Anast JM, Margerum DW. Electron-transfer reactions of copper(III)-peptide complexes with hexacyanoferrate(II). Inorg. Chem. 1982;21:3494-3501.
295. Eichhorn GL, Shin YA. Interaction of metal ions with polynucleotides and related compounds. XII. The relative effect of various metal ions on DNA helicity. J. Am. Chem. Soc. 1968;90:7323-7328.
296. Stupnisek-Lisac E, Karsulin M, Takenouti H. Passivation of iron, nickel and cobalt in concentrated nitric acid solutions. In: Froment M, editor. Passivity of metals and semiconductors. Amsterdam: Elsevier; 1983. pp 327-334.
297. Seaman GT, Myers JR, Saxer RK. Anodic polarization behaviour of cobalt-chromium alloys in sulphuric acid solutions. Electrochim. Acta 1967;12:855-871.
298. Noyes AA, Deahl TJ. Strong oxidizing agents in nitric acid solution. III. Oxidation potential of cobaltouscobaltic salts, with a note on the kinetics of the reduction of cobaltic salts by water. J. Am. Chem. Soc. 1937;59:1337-1344.
299. Nicholls D. Cobalt. In: Bailar JC, Emeléus HJ, Nyholm R Sir, Trotman-Dickenson AF, editors. Comprehensive inorganic chemistry. Oxford: Pergamon Press; 1973. pp 1068-1069.
300. Bjerrum J, McReynolds JP. Hexamminecobalt(III) salts. In: Fernelius WC, editor. Inorganic syntheses. Vol. 2. New York: McGraw-Hill; 1946. pp 216-221.
301. Sunderman Jr FW. Carcinogenicity of metal alloys in orthopedic prostheses: Clinical and experimental studies. Fundam. Appl. Toxicol. 1989;13:205-216.
302. Sirover MA, Loeb LA. Metal activation of DNA synthesis. Biochem. Biophys. Res. Commun. 1976;70:812-817.
303. Kankia BI, Buckin V, Bloomfield VA. Hexamminecobalt(III)-induced condensation of calf thymus DNA: Circular dichroism and hydration measurements. Nucleic Acids Res. 2001;29:2795-2801.
304. Hengstler JG, Bolm-Auorff U, Faldum A, Janssen K, Reifenrath M, Gotte W, Jung D, Mayer-Popken O, Fuchs J, Gebhard S, et al. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis 2003;24:63-73.
305. El Wakkad SES, Emara SH. The anodic oxidation of platinum at very low current density. J. Chem. Soc. 1952;Part 1:461-466.
306. Maugh TH II. A look at the surface of platinum. Science 1984;225:399.
307. Rosenberg B, Van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 1965;205:698-699.
308. Rosenberg B, Van Camp L, Trosko JE, Mansour VH. Platinum compounds: A new class of potent antitumour agents. Nature 1969;222:385-386.
309. Marx JL. Chemotherapy: Renewed interest in platinum compounds. Science 1976;192:774-775.
310. Desoize B. Metals and metal compounds in cancer treatment. Anticancer Res. 2004;24:1529-1544.
311. 32P-postlabelling. Nucleic Acids Res. 1995;23:1300-1306.
312. Lippard SJ, Hoeschele JD. Binding of cis- and trans- dichlorodiammineplatinum(II) to the nucleosome core. Proc. Natl. Acad. Sci. USA 1979;76:6091-6095.
313. Hall MD, Dolman RC, Hambley TW. Platinum(IV) anticancer complexes. Met. Ions Biol. Syst. 2004;42:297-322.
314. 2]. Science 1982;218:1075-1082.
315. Barton JK, Best SA, Lippard SJ, Walton RA. Relationship of cis- diammineplatinum α-pyridone blue to other platinum blues. An x-ray photoelectron study. J. Am. Chem. Soc. 1978;100:3785-3788.
316. Barton JK, Szalda DJ, Rabinowitz HN, Waszczak JV, Lippard SJ. Solid state structure, magnetic susceptibility, and single crystal ESR properties of cis-diammineplatinum α-pyridone blue. J. Am. Chem. Soc. 1979;101:1434-1441.
317. Livingstone SE. The second- and third-row elements of group VIII A, B and C. In: Bailar JC, Emeléus HJ, Nyholm R Sir, Trotman-Dickenson AF, editors. Comprehensive inorganic chemistry. Oxford: Pergamon Press; 1973. p 1330.
318. Kanematsu N, Hara M, Kada T. Rec assay and mutagenicity studies on metal compounds. Mutat. Res. 1980;77:109-116.
319. Nygren O, Lundgren C. Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy. Int. Arch. Occup. Environ. Health 1997;70:209-214.
320. Leopold WR, Miller EC, Miller JA. Carcinogenicity of antitumour cis- platinum(II) coordination complexes in the mouse and rat. Cancer Res. 1979;39:913-918.
321. Gmelin. Molybdenum. In: K. Swars, editor. Gmelin handbook of inorganic chemistry, Suppl. Vol. A3, Reactions with acidic aqueous solutions. Berlin: Springer-Verlag; 1983. p 191.
322. Vanslembrouck P, Bogaerts W, Van Haute A. The role of molybdenum in the inhibition of passivity breakdown in neutral chloride solutions up to 250°C. In: Froment M, editor. Passivity of metals and semiconductors. Amsterdam: Elsevier; 1983. pp 393-398.
323. Barceloux DG. Molybdenum. J. Toxicol. Clin. Toxicol. 1999;37:231-237.
324. Lener J, Bíbr B. Biliary excretion and tissue distribution of penta- and hexavalent molybdenum in rats. Toxicol. Appl. Pharmacol. 1979;51:259-263.
325. Versieck J, Hoste J, Vanballenberghe L, Barbier F, Cornelis R, Waelput I. Serum molybdenum in diseases of the liver and biliary system. J. Lab. Clin. Med. 1981;97:535-544.
326. Nakadaira H, Endoh K, Yamamoto M, Katoh K. Distribution of selenium and molybdenum and cancer mortality in Niigata, Japan. Arch. Environ. Health 1995;50:374-380.
327. Doran A, Law FC, Allen MJ, Rushton N. Neoplastic transformation of cells by soluble but not particulate forms of metals used in orthopaedic implants. Biomaterials 1998;19:751-759.
328. 1 mice (inhalation studies). Natl. Toxicol. Program Tech. Rep. Ser. 1997;462:1-269.
329. Amin JV, Joham HE. A molybdenum cycle in the soil. Soil Sci. 1958;85:156-160.
330. Bautista EM, Alexander M. Reduction of inorganic compounds by soil organisms. Proc. Soil Sci. Soc. Am. 1972;36:918-920.
331. Lewis CG, Sunderman FW. Metal carcinogenesis in total joint arthroplasty. Clin. Orthop. 1996;329(Suppl.):264-268.
332. Dodion P, Putz P, Amiri-Lamraski MH, Efira A, De Martelaere E, Heimann R. Immunoblastic lymphoma at the site of an infected vitallium bone plate. Histopathology 1983;6:807-813.
333. Stevenson S, Hohn RB, Pohler OEM, Fetter AW, Olmstead ML, Wind AP. Fracture-associated sarcoma in the dog. J. Am. Vet. Med. Assoc. 1982;180:1189-1196.
334. Waalkes MP, Rehn S, Kasprzak KS, Issaq HJ. Inflammatory, proliferative, and neoplastic lesions at the site of metallic identification ear tags in Wistar [Crl:(WI)BR] rats. Cancer Res. 1987;47:2445-2450.
335. Bouchard PR, Black J, Albrecht BA, Kaderly RE, Galante JO. Carcinogenicity of CoCrMo (F-75) implants in the rat. J. Biomed. Mater. Res. 1996;32:37-44.
336. Jones DA, Lucas HK, O'Driscoll M, Price CHG, Wibberley B. Cobalt toxicity after McKee hip arthroplasty. J. Bone Joint Surg. 1975;57B:289-296.
337. Coleman RF, Herrington J, Scales JT. Concentration of wear products in hair, blood, and urine after total hip replacement. Br. Med. J. 1973;1:527-529.
338. Wei H-J, Luo X-M, Yang SP. Effects of molybdenum and tungsten on mammary carcinogenesis in SD rats. J. Natl. Cancer Inst. 1985;74:469-473.
339. Luo X-M, Wei H-J, Yang S-P. Inhibitory effects of molybdenum on esophageal and forestomach carcinogenesis in rats. J. Natl. Cancer Inst. 1983;71:75-80.
340. Lu SX, Montesano R, Bresil H, Lu LY, Xiao GL. Effect of molybdenum Mo on the alkylation of DNA in the liver of rats treated with 14C-diethylnitrosamine. Zhonghua Zhong Liu Za Zhi 1987;9:21-24.
341. Visuri T, Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orthopedics 1991;14:137-142.
342. Gillespie WJ, Frampton CMA, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J. Bone Joint Surg. 1988;70B:539-542.
343. Gillespie WJ, Henry DA, O'Connell DL, Kendrick S, Juszczak E, McInneny K, Derby L. Development of hematopoietic cancers after implantation of total joint replacement. Clin. Orthop. 1996;329(Suppl.):290-296.
344. Visuri T, Pukkala E, Paavolainen P, Pulkkinen P, Riska EB. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin. Orthop. 1996;329(Suppl.):280-289.
345. Shin YK, Nocera DG. Intercalation of multiply bonded dimolybdenum core into layered metal phosphates. J. Am. Chem. Soc. 1992;114:1264-1271.